[HTML][HTML] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & diseases, 2015 - Elsevier
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & Diseases, 2015 - sciopen.com
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[引用][C] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & Diseases, 2015 - cir.nii.ac.jp
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & diseases, 2015 - pubmed.ncbi.nlm.nih.gov
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[PDF][PDF] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - 2014 - cyberleninka.org
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer.
K Knickelbein, L Zhang - Genes & Diseases, 2015 - europepmc.org
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[PDF][PDF] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - 2014 - researchgate.net
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[PDF][PDF] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - 2014 - core.ac.uk
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[HTML][HTML] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - Genes & Diseases, 2015 - ncbi.nlm.nih.gov
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
[PDF][PDF] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer
K Knickelbein, L Zhang - 2014 - scienceopen.com
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …